SW

Shaheen Wajid Ali Ansari

Active Director Director DIN 09373684
DIN 09373684 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Shaheen Wajid Ali Ansari

Data last updated:

Shaheen Wajid Ali Ansari is a Director at Pharma Today Publicity And Research Private Limited (since 2021). The company operates in Healthcare.

DIN 09373684
Primary Designation Director
Industry Healthcare
First Appointment 25 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Oct 20212021Active

Directorship timeline

Open interactive timeline →
Pharma Today Publicity And Research Private Limited
Premium access

Shareholding and investment profile for Shaheen Wajid Ali Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaheen Wajid Ali Ansari

Shaheen Wajid Ali Ansari currently holds 1 directorship: Pharma Today Publicity And Research Private Limited (Director, since 25 Oct 2021).

Shaheen Wajid Ali Ansari was first appointed on 25 Oct 2021 as Director at Pharma Today Publicity And Research Private Limited.

The current boards of Shaheen Wajid Ali Ansari's companies include Kishankumar Karamshibhai Goyani (Pharma Today Publicity And Research Private Limited), Nikunj Vinubhai Bharoliya (Pharma Today Publicity And Research Private Limited), Sandip Jagdamba Rajput (Pharma Today Publicity And Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available